An Evidence-Based App to Help MS Patients with Depression
Pear Therapeutics developed the first FDA-approved Prescription Digital Therapeutic (PDT). Echobind worked with them on an app designed to treat depression in patients with MS. 006 is currently in the study pipeline and being evaluated.